FTC Sues Major Pharmacy Benefit Managers Over Inflated Insulin Prices
The FTC has sued major PBMs, accusing them of inflating insulin prices. This lawsuit highlights the detrimental impact on diabetic patients and potential reforms in the pharmaceutical industry.
FTC Sues Major Pharmacy Benefit Managers Over Inflated Insulin Prices Read More »